Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 17 hours agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 3 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for ...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 4 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 21 hours agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 day agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 20 hours agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 7 days agoMerck & Co’s market capitalisation growth of 21% was fuelled by the FDA’s approval of Winrevair, a...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 day agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 2 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...